SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing significant retail and institutional interest, fueled by a positive feature in the Wall Street Journal and community enthusiasm surrounding the company's expanding role in physical AI, robotics, and its QNX software platform. Investors are closely monitoring volume and price action as the community discusses potential breakouts, institutional accumulation, and the stock's long-term growth potential in cybersecurity and automotive technology.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending after NOAA officially determined the company's deep-seabed mining application is in full compliance, providing a clear regulatory path toward commercial recovery permits by 2027. Investors are actively discussing this milestone as a major de-risking event, with many debating the stock's long-term potential as a critical component in the domestic battery metal supply chain.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging following an earnings report that emphasized improved profit margins and robust AI infrastructure demand, helping to alleviate concerns regarding recent legal and regulatory overhangs. Investors and community members are actively debating the company's valuation gap compared to sector peers and monitoring whether this momentum can sustain a potential short squeeze.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant community buzz as investors anticipate potential global partnership announcements and updates regarding its AI-driven immunotherapy manufacturing technology. The discussion is heavily centered on a potential short squeeze, with retail traders pointing to high short interest and limited float as key drivers for a potential sharp upward move.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings Inc. (CELH) is experiencing extreme volatility as shares touch new 52-week lows, fueling intense community debate regarding institutional manipulation versus fundamental concerns like competition from private-label alternatives. Investors are closely monitoring the upcoming earnings release, with many split between those expecting a massive post-earnings rebound and those fearing further downside due to inventory and margin pressures.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubo is experiencing significant volatility as retail investors debate the company's long-term viability and the impact of its partnership with Disney, while the stock faces heavy short interest and skepticism regarding management's profitability targets. The community remains deeply polarized, with bulls pointing to potential strategic synergies and oversold conditions, while bears cite historical subscriber losses and a lack of insider buying as reasons to avoid the stock.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as market sentiment turns bullish, driven by expectations of a blockbuster year for Briumvi, strong commercial execution, and anticipation of upcoming trial readouts for subcutaneous formulations and Azer-cel. The community is actively discussing the potential for a strategic buyout and observing significant institutional accumulation, which many believe is positioning the stock for a breakout beyond current resistance levels.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is trending following a manufacturing collaboration announcement for its ERNA-101 ovarian cancer therapy, driving significant volatility and volume. The community is sharply divided, with bulls pointing to the potential for a short squeeze on the low-float asset, while skeptics warn of historical dilution and the risks inherent in early-stage preclinical biotech.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is seeing high volatility and intense social media discussion as investors debate its valuation ahead of upcoming earnings, with bull-case optimism centering on potential government contracts and strategic acquisitions while bears express concerns over cash burn and dilution. Traders are heavily focused on the stock's recent price swings and potential for a short squeeze, leading to a highly polarized community dialogue regarding the company's long-term quantum computing prospects.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility and intense community debate as investors weigh the company's strong revenue base against regulatory skepticism and mixed trial results. Traders are actively discussing the potential for a massive short squeeze while closely monitoring upcoming earnings and pipeline developments for signs of institutional conviction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Peapod Lane Capital LLC Has $2.47 Million Position in OraSure Technologies, Inc. $OSUR

Peapod Lane Capital LLC raised its stake in OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) by 51.1% during the 4th quarter, according to the company in its most recent disclosure with the...

OraSure Technologies (NASDAQ:OSUR) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?

OraSure Technologies (NASDAQ:OSUR) Stock Price Passes Above 200-Day Moving Average - What's Next...

OraSure Technologies Sees Unusually High Options Volume (NASDAQ:OSUR)

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) was the target of some unusual options trading on Monday. Traders acquired 7,008 call options on the stock. This is an increase of 2,394% compared to the average volume of 281 call options...

OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above Two Hundred Day Moving Average - Here's Why

OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened...

OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200-Day Moving Average - Here's What Happened

OraSure Technologies (NASDAQ:OSUR) Shares Pass Above 200 Day Moving Average - Time to Sell...

Manner Carrie Eglinton Buys 32,300 Shares of OraSure Technologies (NASDAQ:OSUR) Stock

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) CEO Manner Carrie Eglinton purchased 32,300 shares of the stock in a transaction on Friday, March 20th. The shares were purchased at an...

Manner Carrie Eglinton Acquires 32,300 Shares of OraSure Technologies (NASDAQ:OSUR) Stock

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) CEO Manner Carrie Eglinton bought 32,300 shares of the firm's stock in a transaction that occurred on Friday, March 20th. The stock was bought at an average cost of $2.93 per share, for a total transaction of $94,639.00. Following the...

Insider Buying: OraSure Technologies (NASDAQ:OSUR) CFO Purchases 32,300 Shares of Stock

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) CFO Kenneth Mcgrath bought 32,300 shares of the business's stock in a transaction on Friday, March 20th. The stock was bought at an average price of $2.93 per share, for a total transaction of $94,639.00. Following the transaction, the...

Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance

Altai Capital Management, L.P. ('Altai'), one of the largest shareholders and the beneficial owners of approximately 5% of the outstanding common stock of OraSure Technologies, Inc. (OraSure or the...

OraSure Technologies (NASDAQ:OSUR) CFO Purchases $66,063.00 in Stock

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) CFO Kenneth Mcgrath acquired 22,021 shares of OraSure Technologies stock in a transaction that occurred on Friday, March 13th. The shares...

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.

Orasure Technologies Inc.

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.23	--	--	N/A
Q4 '25	-$0.20	-$0.27	-31.71%	MISSED
Q3 '25	-$0.19	-$0.19	--	EXPECTED
Q2 '25	-$0.20	-$0.26	-26.83%	MISSED
Q1 '25	-$0.16	-$0.21	-28.57%	MISSED

OSUR
Orasure Technologies Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest OSUR News

OSUROrasure Technologies Inc.